New chemo combo aims to boost survival in kids with rare lymphoma
NCT ID NCT02845882
First seen Mar 18, 2026 · Last updated Apr 29, 2026 · Updated 8 times
Summary
This study tests a modified chemotherapy regimen for Chinese children and teens newly diagnosed with lymphoblastic lymphoma. The goal is to improve survival rates compared to previous treatments. About 150 participants will receive the adjusted therapy, and researchers will track how long they stay cancer-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOBLASTIC LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Children's Medical Center
Shanghai, 200127, China
-
West China Second University Hospital
Chengdu, China
Conditions
Explore the condition pages connected to this study.